Status:
COMPLETED
Effectiveness of Saline Water and Lidocaine Injections for the Treatment of Intractable Plantar Keratoma
Lead Sponsor:
Université du Québec à Trois-Rivières
Conditions:
Intractable Plantar Keratoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An intractable plantar keratoma (IPK) is a conical thickening of the epidermis' stratum corneum and a common cause of foot pain which can have a significant, detrimental impact on the mobility, qualit...
Eligibility Criteria
Inclusion
- • Having a painful IPK for at least 3 months
Exclusion
- Ongoing pregnancy or breastfeeding
- Severe cardiovascular or neurological disease
- Immunosuppressed status
- Presence of a plantar ulcer
- Allergy to lidocaine
- History of keloid or hypertrophic scar
- Simultaneous painful plantar syndrome unrelated to the presence of an IPK
Key Trial Info
Start Date :
June 7 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04777227
Start Date
June 7 2015
End Date
September 15 2019
Last Update
March 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique podiatrique de l'Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada, G8Z 4M3